Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States

BMC Ophthalmology

Volumn 9, Issue 1, 2009, Pages

  Smith, Andrew F ^a,b   Waycaster, Curtis ^c  

^a Medmetrics Inc   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Health Economics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; CONJUNCTIVITIS; ECONOMICS; HEALTH CARE COST; HUMAN; INCIDENCE; MICROBIOLOGY; REVIEW; UNITED STATES;

BACTERIAL INFECTIONS; CONJUNCTIVITIS; HEALTH CARE COSTS; HUMANS; INCIDENCE; UNITED STATES;

EID: 73849120339     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-9-13     Document Type: Article

References (39)

1. Bacterial conjunctivitis. MJ Mannis RD Plotnick, Duane's Clinical Ophthalmology Philadelphia: Lippincott-Raven, Tasman W, Jaeger EA, 2004 4 1 7
2. Bacterial conjunctivitis. C Chung E Cohen J Smith, Clin Evid 2002 7 574 12230683
3. Common ocular infections: a prescriber's guide. SP Donahue JM Khoury RP Kowalski, Drugs 1996 52 526 40 10.2165/00003495-199652040-00006 8891465
4. Update on bacterial conjunctivitis in South Florida. K Cavuoto D Zutshi CL Karp D Miller W Feuer, Ophthalmology E-publication ahead of press 2007 17572497
5. American Academy of Ophthalmology, Preferred practice pattern: conjunctivitis. Published 2003
6. Overview of the potency of moxifloxacin ophthalmic solution 0.5% (VIGAMOX). BA Schlech E Alfonso, Surv Ophthalmol 2005 50 Suppl 1 7 15 10.1016/j.survophthal.2005.05.002 16257313
7. An outbreak of epidemic keratoconjunctivitis in a pediatric unit due to adenovirus 8. IF Chaberny P Schnitzler HK Geiss C Wendt, Infect Control Hosp Epidemiol 2003 24 514 519 10.1086/502247 12887240
8. Update on emerging infections: news from the Centers for Disease Control and Prevention. FM Abrahamian, MMWR Morb Mortal Wkly Rep 2002 51 205 207 11922188
9. The outbreak of conjunctivitis at Dartmouth. EK Feingold, N Engl J Med 2003 348 2577 2578 10.1056/NEJM200306193482517 12815147
10. A community outbreak of conjunctivitis caused by nontypeable Streptococcus pneumoniae in Minnesota. JM Buck C Lexau M Shapiro A Glennen DJ Boxrud B Koziol CG Whitney B Beall R Danila R Lynfield, Pediatr Infect Dis J 2006 25 906 911 10.1097/01.inf.0000238143.96607.ec 17006286
11. IMS, NDTI (National Drug and Therapeutic Index) data, MAT (Moving Annual Trend). 2000
12. Efficacy and safety of 0.5% Levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in pediatric patients. SJ Lichtenstein M Rinehart, et al. J-AAPOS 2003 7 317 324 10.1016/S1091-8531(03)00168-X 14566313
13. Acute bacterial conjunctivitis. G Hovding, Acta Ophthalmol Scand 2008 86 5 17
14. M McCormick D Fleming J Charlton, Morbidity statistics from general practice: Fourth National Survey 1991-1992 London, HMSO 1995
15. Eye disease at a community health centre. JKG Dart, Br-Med-J 1986 293 1477 1480 10.1136/bmj.293.6560.1477
16. How do GP's diagnose and manage acute infective conjunctivitis? A GP survey. H Everitt P Little, Fam Pract 2002 19 658 660 10.1093/fampra/19.6.658 12429670
17. Predicting bacterial cause in infectious conjunctivitis: cohort study on informativeness of combination signs and symptoms. RP Rietveld G ter Riet PJE Bindels JH Sloos HCPM van Weert, Br Med J 2004 329 206 208 10.1136/bmj.38128. 631319.AE
18. Genees en hulpmiddelen Informatie Project. Annual report prescription data College voor zorgverzekeringen. Amstelveen 2001
19. Department of Health, Prescription cost analysis data Leeds: Department of Health 1998
20. The economic costs of illness: a replication and update. DP Rice TA Hodgson AN Kopstein, Care Finance Rev 1985 7 61 80
21. Cost of illness methodology; a guide to current practices and procedures. TA Hodgson M Meiners, Milbank Q 1982 60 3 429 462
22. The state of the art of cost of illness estimates. TA Hodgson, Advanced Health Economic Health Service Res 1983 4 29 64
23. Canadian Institute for Health Information, National health expenditure trends (NHEX) 1975-2000
24. Physician Fee Schedule Search. http://www.cms.hhs.gov/PFSlookup/02- PFSSearch.asp Accessed 1st October 2009
25. National Ambulatory Medical Care Survey (NAMCS) 2005 dataset, personal correspondence Don Cherry, Center for Disease Control (CDC), National Center for Health Statistics, NAMCS. 2007
26. Classification of Diseases and Injuries. ftp://ftp.cdc.gov/pub/Health- Statistics/NCHS/Publications/ICD-9/ucod.txt Accessed 20 December 2007
27. nd October 2009
28. 2004 Red Book Pharmacy's Fundamental Reference, Thomson PDR, Montvale, NJ.
29. Databases, Tables & Calculators by Subject. http://data.bls.gov?PDQ/ servlet/SurveyOutputServlet Accessed 25 February 2008
30. Handling uncertainty in economic evaluations of healthcare interventions. AH Briggs AM Gray, BMJ 1999 319 635 638 10473486
31. Geographic Comparison Table. http://factfinder.census.gov/servlet/ GCTTable?-bm=y&-geo-id=01000US&--box-head-nbr=GCT-T1-R&-ds-name= PEP-2006-EST&--lang=en&-redoLog=false&-mt-name=PEP-2007-EST-GCTT1R- US9S&-format=US-9S Accessed 20th December 2007
32. http://www.factfinder.census.gov/servlet/DTTable?-bm=y&-geo-id= 01000US&-ds-name=ACS-2008-3YR-G00-&-redoLog=false&-mt-name= ACS-2008-3YR-G2000-B02001 Accessed 15 June 2008
33. Health, United States, 2007. http://www.cdc.gov/nchs/data/hus/hus07.pdf Accessed 12 June 2008
34. The economic burden of major adult visual disorders in the United States Arch. DB Rein P Zhang KE Wirth PP Lee TJ Hoerger N McCall R Klein JM Tielsch S Vijan J Saaddine, Ophthalmol 2006 124 12 174 60
35. Cost of refractive correction of distance vision impairment in the United States, 1999-2002. S Viatale MF Cotch R Sperduto L Ellwein, Ophthalmology 2006 113 2163 70 10.1016/j.ophtha.2006.06.033 16996610
36. Economic impact of visual impairment and blindness in the United States. KD Frick EW Gower JH Kempen JL Wolff, Arch Ophthalmol 2007 125 544 50 10.1001/archopht.125.4.544 17420375
37. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study. AF Cruess G Zlateva X Xu G Soubrane D Pauleikhoff A Lotery J Mones R Buggage C Schaefer T Knight TF Goss, Pharmacoeconomics 2008 26 57 73 10.2165/00019053-200826010-00006 18088159
38. The economic burden of diabetic retinopathy in Germany in 2002. M Happich U Reitberger L Breitscheidel M Ulbig J Watkins, Graefe's Arch Clin Exp Ophthalmol 2008 246 151 159 10.1007/s00417-007-0573-x (Pubitemid 350162696)
39. A Multicenter Comparison of Polymyxin B Sulfate/Trimethoprim Ophthalmic Solution and Moxifloxacin in the Speed of Clinical Efficacy for the Treatment of Bacterial Conjunctivitis. DB Granet M Dorfman D Stroman P Cockrum, Journal of Pediatric Ophthalmology and Strabismus Accepted for publication Oct. 2008